4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-429071
Director bought 9,411 shares at an average $26.45 ($248,891)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MARAGANORE JOHN Director | 2026-10-22 | Purchase | +8,239 | $26.38 | $217,344 | 8,239 | I: show line 1 in the form |
| MARAGANORE JOHN Director | 2026-10-22 | Purchase | +1,172 | $26.92 | $31,547 | 9,411 | I: show line 2 in the form |
| Open-market purchases · 9,411 sh · avg $26.45 · $248,891 | |||||||
Loading xslF345X06/ownership.xml…